HeLa-Difluo™ hLC3 Cells

Product Unit size Cat. code Docs. Qty. Price

HeLa-Difluo™ hLC3 Cells

Autophagy Reporter Cells

Show product

3-7 x 10e6 cells

  • About
  • Specifications
  • Contents
  • Related products

Monitoring autophagy activity 

HeLa-Difluo™ hLC3 reporter cells are designed to monitor the autophagic flux by means of a fluorescent-labeled LC3B protein.

These cells, derived from the HeLa human epithelial carcinoma cell line, express the RFP::GFP::LC3 fusion protein where the human LC3B (microtubule-associated protein 1 light chain 3 beta) is fused to two fluorescent reporter proteins: RFP (acid-stable) and GFP (acid-sensitive). The LC3B protein is a good marker to assess the autophagic flux since it is recruited from the cytosol to be associated to all the autophagic structures: the nascent autophagosome (called the isolation membrane), the complete autophagosome and the autolysosome. Upon autophagy induction, diffuse cytoplasmic fluorescence shifts to autophagosomes and autolysosomes as fluorescent puncta. 

Monitoring of autophagy activity relies on microscopy visualization of fluorescent puncta, progressive degradation of the GFP, and concurrent increase of RFP signal in autolysosomes. The number of fluorescent punctate structures per cell, the percentages of RFP-GFP positive and RFP positive cells can be used to assess autophagic flux as described previously [1,2]

HeLa-Difluo™ hLC3 cells are resistant to Zeocin®.



1. Loos B. et al. 2014. Defining and measuring autophagosome flux- concept and reality. Autophagy. 2014;10(11):2087-96.
2. Kimura s. et al., 2007. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescenttagged LC3. Autophagy. 3(5):452-60.


Detection of fluorescent puncta from rapamycin-mediated autophagy in Hela-Difluo cells
Detection of fluorescent puncta from rapamycin-mediated autophagy in Hela-Difluo cells

Detection of fluorescent puncta from rapamycin-mediated autophagy in HeLa-Difluo cells.

Cells were treated 25µM rapamycin and analyzed by fluorescent microscopy at 2 hours of incubation. Culture media is changed and cells were incubated for 4 additional hours. The microscopy image show red-colored autophagolysosomes and red and green double-colored autophagosomes in Hela-DiFluo treated cells.

Back to the top


Antibiotic resistance: Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™.

Quality control:

  • HeLa-Difluo™ hLC3 cells have been tested for their ability to respond to autophagic inducers.
  • The stability of this cell line for 20 passages following thawing has been verified.
  • HeLa-Difluo™ hLC3 cells are guaranteed mycoplasma-free.

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top


  • 1 vial of HeLa-Difluo™ hLC3 Cells (3-7 x 106 cells)
  • 100 μl Zeocin® (100 mg/ml).
  • 1 ml Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria and fungi.

Dry ice shipping Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

See Data Sheet for storage conditions of each component.

Back to the top

Notification:  This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty